In the present study, we demonstrated that high expression levels of CCL8 mRNA in tumor tissues were associated with poor prognosis of patients with stage I–III CRC (Figure 6C), implying that CCL8 may be a useful prognostic biomarker for patients with CRC. This evidence concerns the gene CCL8 and neoplasm.